Exchange: NASDAQ·Updated 03:59 PM EDT
BTAI logo

BTAI BioXcel Therapeutics Inc

$0.013
$0.0005
(3.70%)
Today
Reported EarningsMay 15
Mkt Cap$406,971.00
Vol114,934.00

About BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
56

Bullish Sentiment

How do you feel about BTAI?

Zbrazeau
$BTAI this is somewhat interesting. As there very could have been one, if not multiple bid submissions already but they only have to be name designsted bidders and release in a filing by Oct 13 I believe. If a bidder comes in with say. 100M offer cash plus another 100M on a contingency of milestones being reached retail makes money. Even after the waterfall for the collection of debts. With the example above of 200M if all milestones are reached.( More specifically the fda approval for at home use) I calculate out approx a ~1.5 per share price but this is just an opinion. And it will be interesting to see how it pans out.
1
5
Zbrazeau
$BTAI I took a very modest position in this….but how is this getting any volume. It’s cooked. Shares are worthless. Unless something magical happens. Does someone have an explanation

Advertisement|Remove ads.